Clinical Trial Update: A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports results for coadministration of the Recombinant Hepatitis E Vaccine (Escherichia Coli) with a Recombinant Hepatitis B Vaccine. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis E

Drugs mentioned

• Recombinant Hepatitis E Vaccine (Escherichia Coli) (Hepatitis E vaccine (recombinant, E. coli expression))
• Recombinant hepatitis B vaccine (hepatitis B vaccine, recombinant)

Snippet

Sponsor: Xiamen Innovax Biotech Co., Ltd | Conditions: Hepatitis E, Hepatitis B | Phase 4 | Status: COMPLETED